Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

CFO and CBO

President and Chief Executive

Chief Operating Officer

Phathom Pharmaceuticals, Inc., biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada for an investigational potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. Phathom Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Florham Park, New Jersey.

Phathom Pharmaceuticals, Inc., biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseas...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-08	Premium	sold	Premium	Premium	Premium	CFO and CBO
2024-03-22	Premium	sold	Premium	Premium	Premium	President and Chief Executive
2024-01-24	Premium	sold	Premium	Premium	Premium	-
2024-01-19	Premium	sold	Premium	Premium	Premium	CFO and CBO
2023-11-20	Premium	sold	Premium	Premium	Premium	CFO and CBO
2023-11-08	Premium	bought	Premium	Premium	Premium	-
2023-11-07	Premium	bought	Premium	Premium	Premium	-
2023-11-06	Premium	bought	Premium	Premium	Premium	-
2023-11-01	Premium	acquired	Premium	Premium	Premium	CFO and CBO
2023-11-01	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2023-11-01	Premium	acquired	Premium	Premium	Premium	President and Chief Executive
2023-11-01	Premium	sold	Premium	Premium	Premium	CFO and CBO
2023-07-14	Premium	acquired	Premium	Premium	Premium	CFO and CBO
2023-07-14	Premium	acquired	Premium	Premium	Premium	CFO and CBO
2023-07-14	Premium	acquired	Premium	Premium	Premium	President and Chief Executive
2023-07-14	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2023-06-02	Premium	acquired	Premium	Premium	Premium	-
2023-06-02	Premium	sold	Premium	Premium	Premium	CFO and CBO
2023-05-25	Premium	acquired	Premium	Premium	Premium	-
2023-05-25	Premium	acquired	Premium	Premium	Premium	-
2023-05-25	Premium	acquired	Premium	Premium	Premium	-
2023-05-25	Premium	acquired	Premium	Premium	Premium	-
2023-05-25	Premium	acquired	Premium	Premium	Premium	-
2023-05-25	Premium	acquired	Premium	Premium	Premium	-
2023-05-25	Premium	acquired	Premium	Premium	Premium	-

PHAT - Phathom Pharmaceuticals Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for PHAT